Literature DB >> 4025276

Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases.

N D Vaziri, B Dure-Smith, R Miller, M K Mirahmadi.   

Abstract

The pathological data obtained from postmortem examination of the gastrointestinal tract in 78 chronic hemodialysis patients are reported. All but two of the patients exhibited some gastrointestinal abnormalities. Multiple abnormalities often coexisted in one individual. Esophagitis, gastritis, duodenitis, enteritis, and colitis were seen with considerable frequency. However, extensive hemorrhagic, ulcerative, and pseudomembranous lesions frequently seen in untreated uremia were generally lacking. Evidence of peptic ulcer disease was found in one-fourth of the patients confirming the increased predisposition of dialysis patients to this complication. Several patients exhibited various ischemic phenomena including thrombosis, embolism, and infarction of various segments of the gastrointestinal tract. In addition, numerous other abnormalities were found throughout the gastrointestinal tract with lesser frequency. The data indicate that various gastrointestinal abnormalities commonly occur in patients with endstage renal disease despite uremia control by hemodialysis. However, the observed abnormalities are different from those reported in untreated uremia.

Entities:  

Mesh:

Year:  1985        PMID: 4025276

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  46 in total

1.  Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.

Authors:  Wei Ling Lau; Shu-Man Liu; Sogol Pahlevan; Jun Yuan; Mahyar Khazaeli; Zhenmin Ni; Jefferson Y Chan; Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.

Authors:  Rabi Yacoub; Girish N Nadkarni; Daniel I McSkimming; Lee D Chaves; Sham Abyad; Mark A Bryniarski; Amanda M Honan; Shruthi A Thomas; Madan Gowda; John C He; Jaime Uribarri
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-12

Review 3.  An update on the role of the inflammasomes in the pathogenesis of kidney diseases.

Authors:  Murthy N Darisipudi; Felix Knauf
Journal:  Pediatr Nephrol       Date:  2015-07-16       Impact factor: 3.714

Review 4.  Metabolic Abnormalities in Diabetes and Kidney Disease: Role of Uremic Toxins.

Authors:  Laetitia Koppe; Denis Fouque; Christophe O Soulage
Journal:  Curr Diab Rep       Date:  2018-09-08       Impact factor: 4.810

Review 5.  Targeting gut microbiota: a potential promising therapy for diabetic kidney disease.

Authors:  Zhonge Chen; Shuishan Zhu; Gaosi Xu
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

6.  Wireless capsule endoscopy in the investigation of patients with chronic renal failure and obscure gastrointestinal bleeding (preliminary data).

Authors:  Stephanos Karagiannis; Spyros Goulas; Georgios Kosmadakis; Petros Galanis; Dimitrios Arvanitis; John Boletis; Evangelos Georgiou; Christos Mavrogiannis
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

7.  Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease.

Authors:  Nosratola D Vaziri; Jun Yuan; Keith Norris
Journal:  Am J Nephrol       Date:  2012-12-19       Impact factor: 3.754

8.  Pathology of digestive organs in renal transplant recipients.

Authors:  M V Pahl; N D Vaziri; D C Martin
Journal:  J Natl Med Assoc       Date:  1986-08       Impact factor: 1.798

Review 9.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

Review 10.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Authors:  Ali Ramezani; Ziad A Massy; Björn Meijers; Pieter Evenepoel; Raymond Vanholder; Dominic S Raj
Journal:  Am J Kidney Dis       Date:  2015-11-15       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.